Zobrazeno 1 - 10
of 178
pro vyhledávání: '"R, Lionetto"'
Publikováno v:
Clinical Breast Cancer. 5:358-363
Sixty-eight patients with inflammatory breast carcinoma (IBC) received treatment in 2 prospective randomized trials of multimodality therapy for locally advanced breast cancer. The treatment plan consisted of 3 courses of neoadjuvant chemotherapy wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c762bc5a49e7fb4eb601576e39d1be5a
https://doi.org/10.3816/cbc.2004.n.042
https://doi.org/10.3816/cbc.2004.n.042
Publikováno v:
European Journal of Cancer. 39:1895-1898
The aim of this study was to investigate the possible impact of the treating institution on the survival of patients with advanced squamous cell carcinoma of the head and neck treated with radiotherapy alone or concomitant alternating chemotherapy an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be69dee2854b0e20746f8d71bd4ba9e
https://doi.org/10.1016/s0959-8049(03)00487-8
https://doi.org/10.1016/s0959-8049(03)00487-8
Autor:
Franco Mosca, Paolo Bruzzi, Tiziana Prochilo, Editta Baldini, Manuela Roncella, Pierfranco Conte, G. Gardin, R. Lionetto, P. G. Giannessi, Paola Collecchi, R. Rosso, G Evangelista
Publikováno v:
Annals of Oncology. 14:227-232
Background The purpose of this study was to evaluate the impact of a dose-dense primary chemotherapy on pathological response rate (pCR) in patients with locally advanced breast cancer (LABC) treated with combined modality therapy. Patients and metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29ba8835a148bad9839b5907d83c02a
https://doi.org/10.1093/annonc/mdg069
https://doi.org/10.1093/annonc/mdg069
Autor:
Lucia Del Mastro, R. Lionetto, Stefania Vecchio, A. Alama, G. Gardin, Mario Roberto Sertoli, Paolo Pronzato, Paola Queirolo, Marco Venturini
Publikováno v:
Oncology. 60:88-93
Objective: To identify through a substudy of a larger, multicenter study of adjuvant treatment in primary operable breast cancer patients any possible correlation between cellular proliferation rate, measured by thymidine labeling index (TLI), and pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79b4aa4594dcabe139a209ff199a7b6b
https://doi.org/10.1159/000055302
https://doi.org/10.1159/000055302
Autor:
Marco Ponte, Ferdinando Cafiero, Paola Queirolo, Mario Roberto Sertoli, Marco Gipponi, Giovanni Melioli, Alberto Peressini, Claudia Semino, Iole Ribizzi, Stefania Vecchio, Gabriella Pietra, R. Lionetto
Publikováno v:
Annals of Surgical Oncology. 6:272-278
Background: On the basis of our previous experience, we designed this study to determine the activity and toxicity of outpatient treatment with autologous tumor-infiltrating lymphocytes (TIL) together with intermediate-dose recombinant interleukin-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fd012cc7af24aa022d0fc1b431e6826
https://doi.org/10.1007/s10434-999-0272-4
https://doi.org/10.1007/s10434-999-0272-4
Autor:
Alessandro Comandone, Antonella Romanini, Marco Piolini, Armando Santoro, Sergio Frustaci, Luigi Dogliotti, Alberto Rosso, Carla Dani, Domenico De Toma, Gaetano Apice, Claudio Verusio, Paolo Bruzzi, R. Lionetto, P. Bergnolo
Publikováno v:
Sarcoma
Sarcoma, Vol 3, Iss 3-4, Pp 177-181 (1999)
Scopus-Elsevier
Sarcoma, Vol 3, Iss 3-4, Pp 177-181 (1999)
Scopus-Elsevier
Purpose. The prognosis of advanced soft tissue sarcoma is poor, only a few drugs showing some activity with response rates around 15– 25%. Consequently drug development seems mandatory to improve treatment outcome. Following previous favourable EOR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1ea0f54503bc54062841e0090f68d82
http://europepmc.org/articles/PMC2395431
http://europepmc.org/articles/PMC2395431
Publikováno v:
British Journal of Cancer
Twenty patients with non-Hodgkin's lymphoma were treated with a combination of cyclophosphamide (750 mg m(-2), day 1), epidoxorubicin (60 mg m(-2), day 1), vincristine (1.4 mg m(-2), day 1) and prednisone (100 mg m(-2), days 1-5) every 14 days. Short
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e6cfca0a508f30c7f8c7b163429b59
http://europepmc.org/articles/PMC2062972
http://europepmc.org/articles/PMC2062972
Autor:
M. Venturini, Riccardo Rosso, L. Del Mastro, Mario Roberto Sertoli, Fabio Latini, Ornella Garrone, R. Lionetto, Paola Queirolo, Marco Danova, Claudio Lanfranco, F. Testore, Andrea Ardizzoni
Publikováno v:
Cancer Chemotherapy and Pharmacology. 38:487-494
To verify whether the association of granulocyte-macrophage colony-stimulating factor (GM-CSF) and erythropoietin (EPO) would allow both the acceleration and the dose escalation of the cyclophosphamide/epidoxorubicin/5-fluorouracil (CEF) regimen as f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37d6267ce56b334225b5a3cc5b9b571d
https://doi.org/10.1007/s002800050516
https://doi.org/10.1007/s002800050516
Autor:
A Ardizzoni, M Venturini, MR Sertoli, PG Giannessi, F Brema, M Danova, F Testore, GL Mariani, MC Pennucci, P Queirolo, S Silvestro, P Bruzzi, R Lionetto, F Latini, R Rosso
Publikováno v:
British Journal of Cancer
A randomised study was conducted in 62 patients with advanced breast cancer to assess whether granulocyte-macrophage colony-stimulating factor (GM-CSF) would yield an increase in the dose intensity of a standard-dose CEF regimen through an accelerati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c4e2f79d538b407a946a0aab94e6d3
https://doi.org/10.1038/bjc.1994.71
https://doi.org/10.1038/bjc.1994.71
Autor:
C. Martinoli, M. Onetto, R. Lionetto, L. Fazzuoli, G. Rollandi, S. Saccomanno, A. Allegretto, V. Pugliese, M. Marugo, Michela Paganuzzi
Publikováno v:
Oncology. 50:77-80
In this phase II study, we treated 7 patients, all males, with stage III or IV pancreatic cancer with goserelin (an LH-RH analogue). Goserelin was administered at a dose of 3.6 mg every 4 weeks. The tumour response was assessed by measuring lesions w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8e56e2741c8d92ec010740087b571b2
https://doi.org/10.1159/000227152
https://doi.org/10.1159/000227152